Skip to content

MiniMed® 630G MMT-1715KL (UDI 00763000072520)Recalls & reported problems

Medtronic Minimed, Inc. · PUMP MMT-1715KL 630G V2.8 BK SF MG · Class 3

All models of MiniMed 630G (23)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

4 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.

Quick summary

This MiniMed 630G insulin pump is part of an artificial pancreas system. Reports often describe blank displays, cracked or broken parts, and user interaction problems, and some describe high blood sugar. The FDA database lists 1,294 reports, with 270 injuries and 4 deaths. The 4 open recalls cover insulin over- or under-delivery when the pump is raised or lowered, battery life loss after impacts, a cybersecurity weakness, and a battery cap that can cut power.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
1,294
Deaths reported
4
Injuries reported
270
Recalls naming it
4

Summary

The FDA's MAUDE database contains 1,294 adverse event reports that list this exact device (DI 00763000072520), received between Mar 29, 2018 and Jul 25, 2023 — classified as 4 deaths, 270 injuries, 1,020 malfunctions.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (456 reports).

4 FDA recall records name this device's identifier, 4 still open.

8 other recalls cover devices cleared under the same FDA submission (P150001); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Feb 13, 2026Class IIOpen, Classified

    All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

    Z-1748-2026 · Root cause: Device Design · Recall details · FDA record ↗

  2. Jul 31, 2024Class IOpen, Classified

    Insulin pumps that have been dropped, bumped, or experienced physical impact may have damage to internal electrical components, which may cause reduced pump battery life. Since the defect reduces the battery life overall, it shortens the time between low battery alarms and increases the frequency with which the user must insert a new battery. Further, the defect may also deliver the low battery alarm when there is significantly less time before the battery completely runs out, from the expected up to 10-hour buffer the low alert is supposed to signal, leading to device powering down and stopping insulin delivery unexpectedly. Per the firm, a subset of pumps with the defect showed the low alert alarm was delivered ~2.5 hours before the device shut off, however, patient reports indicate the time could be even shorter. Replacing the battery will not resolve this issue and the short battery life and the truncated low battery alert lead time will continue to occur. Early battery depletion could result in power loss and insulin delivery could be interrupted, resulting in under delivery of insulin potentially leading to hyperglycemia and/or DKA.

    Z-0001-2025 · Root cause: Device Design · Recall details · FDA record ↗

  3. Sep 20, 2022Class IIOpen, Classified

    Medtronic identified a cybersecurity vulnerability in the MiniMed 600 series Insulin Pump Systems associated with the communication protocol that could allow unauthorized access to the pump system. This unauthorized access could be used to deliver too much or too little insulin through delivery of an unintended insulin bolus or because insulin delivery is slowed or stopped, which could lead to hypoglycemia or hyperglycemia. The Remote Bolus feature on insulin pumps should be turned off to prevent the unauthorized access.

    Z-0193-2023 · Root cause: Component change control · Recall details · FDA record ↗

  4. May 23, 2022Class IIOpen, Classified

    Due to battery cap deterioration, this may potentially result in an incomplete battery circuit (similar to when battery cap is not attached) and a loss of power/functionality of the insulin infusion pumps.

    Z-1353-2022 · Root cause: Device Design · Recall details · FDA record ↗

Most reported problems

Device problems

  • Patient Device Interaction Problem456
  • Adverse Event Without Identified Device or Use Problem194
  • No Display/Image157
  • No Apparent Adverse Event151
  • Break100
  • Appropriate Device Problem Term/Code Not Available95
  • Material Integrity Problem91
  • Connection Problem85

Patient problems

  • No Consequences Or Impact To Patient760
  • Hyperglycemia298
  • No Clinical Signs, Symptoms or Conditions162
  • Hypoglycemia84
  • Elevated Ketones/ Diabetic Ketoacidosis17
  • Nausea6
  • Death5
  • Blood Loss4

Recent adverse event reports

The 25 most recent of 1,294 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 25, 2023Obstruction of Flow; Obstruction of Flow

    INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE CUSTOMER WAS HOSPITALIZED AND IN EMERGENCY ROOM DUE TO HIGH BLOOD GLUCOSE VALUE AND THE CUSTOMER DOES NOT WEAR PUMP FOR 11 DAYS. THE CUSTOMER WAS TREATED WITH INSULIN DRIP AND SEVERAL BAGS OF ANTIBIOTICS. TROUBLESHOOTING WAS PERFORMED. THE CUSTOMER ALSO REPORTED INSULIN FLOW BLOCK AND WAS RESOLVED BY COMPLETE SET CHANGE. THE CUSTOMER ALSO EXPERIENCED DIABETES KETO ACIDOSIS. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED. THE CUSTOMER WILL DISCONTINUE THE USE OF THE INSULIN PUMP AND WILL BE RETURNED FOR ANALYSIS.

    Patient problems: Elevated Ketones/ Diabetic Ketoacidosis; Hyperglycemia

    MAUDE report 17386575 ↗
  • MalfunctionAug 2, 2022Patient Device Interaction Problem; Patient Device Interaction Problem

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15143653 ↗
  • MalfunctionJul 23, 2022Break; Break

    INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD HAIRLINE CRACK ON CASING SIDE. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER WILL DISCONTINUE USE OF THE DEVICE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15090218 ↗
  • MalfunctionJul 18, 2022Patient Device Interaction Problem; Patient Device Interaction Problem

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15041404 ↗
  • MalfunctionJul 18, 2022Break; Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS AN ALLEGATION OF HYPERGLYCEMIA AS A RESULT OF THIS EVENT.

    Patient problems: Hyperglycemia

    MAUDE report 15040808 ↗
  • MalfunctionJul 18, 2022Patient Device Interaction Problem; Patient Device Interaction Problem

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15039558 ↗
  • MalfunctionJul 11, 2022Break; Break

    INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE RESERVOIR LIP RING WAS CHIPPED. THE RESERVOIR WAS ABLE TO LOCK IN PLACE WHEN INSERTED INTO THE INSULIN PUMP. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WAS RETURNED FOR ANALYSIS.

    Patient problems: Hyperglycemia

    MAUDE report 14983573 ↗
  • MalfunctionJul 11, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS AN ALLEGATION OF HYPERGLYCEMIA AS A RESULT OF THIS EVENT.

    Patient problems: Hyperglycemia

    MAUDE report 14975714 ↗
  • MalfunctionJul 11, 2022Patient Device Interaction Problem; Patient Device Interaction Problem

    INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT THE INSULIN PUMP HAD A DAMAGED RETAINER RING AND RESERVOIR ABLE TO LOCK IN PLACE. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE CUSTOMER WILL DISCONTINUE TO USE THE DEVICE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14975706 ↗
  • MalfunctionJul 8, 2022Patient Device Interaction Problem; Patient Device Interaction Problem

    INFORMATION RECEIVED BY MEDTRONIC INDICATED THAT INSULIN PUMP RETAINER RING WAS DAMAGED. CUSTOMER REPORTED THAT THE RESERVOIR WAS ABLE TO LOCK IN PLACE WHEN INSERTED INTO PUMP. NO HARM REQUIRING MEDICAL INTERVENTION WAS REPORTED. THE INSULIN PUMP WILL BE RETURNED FOR ANALYSIS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14955393 ↗
  • MalfunctionJul 8, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14954763 ↗
  • MalfunctionJul 8, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14954716 ↗
  • MalfunctionJul 8, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14954677 ↗
  • MalfunctionJul 8, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14954262 ↗
  • MalfunctionJul 8, 2022Break; Material Integrity Problem

    MEDTRONIC RECEIVED INFORMATION THAT BATTERY CAP CRACKED/DAMAGED, DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14954064 ↗
  • MalfunctionJul 8, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14953114 ↗
  • MalfunctionJul 8, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14952598 ↗
  • MalfunctionJul 7, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14952422 ↗
  • MalfunctionJul 7, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14952415 ↗
  • MalfunctionJul 7, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14952292 ↗
  • MalfunctionJul 7, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS AN ALLEGATION OF HYPERGLYCEMIA AS A RESULT OF THIS EVENT.

    Patient problems: Hyperglycemia

    MAUDE report 14951446 ↗
  • MalfunctionJul 7, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14951363 ↗
  • MalfunctionJul 7, 2022Battery Problem; Power Problem

    MEDTRONIC RECEIVED INFORMATION THAT UNEXPECTED BATTERY POWER LOSS, LOW BATTERY ALERT LESS THAN 1 WEEK OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14951157 ↗
  • MalfunctionJul 7, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14951129 ↗
  • MalfunctionJul 7, 2022Break

    MEDTRONIC RECEIVED INFORMATION THAT DAMAGE (PHYSICAL OR COSMETIC) OCCURRED. THERE WAS NO ADVERSE IMPACT OR CONSEQUENCE REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14950921 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P150001. One submission often covers many models, so check the product and lot details in each record.

  • Z-1740-2026 · Feb 13, 2026 · Open, Classified
    MiniMed 630G Insulin Pump (MMT-1714, MMT-1715, MMT-1754, MMT-1755)
  • Z-1259-2025 · Jan 31, 2025 · Open, Classified
    MiniMed insulin pump, REF: 630G (MMT-1714, MMT-1715, MMT-1754, MMT-1755)
  • Z-0855-2022 · Jan 27, 2022 · Open, Classified
    MiniMed 630G: MMT-1715, MMT-1754, MMT-1755; MiniMed 670G: MMT-1740, MMT-1741, MMT-1742, MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782; MiniMed 770G: MMT-1880, MMT-1881
  • Z-0517-2021 · Apr 30, 2020 · Open, Classified
    MiniMed 630G with SmartGuard, insulin pump, Ref/Model # MMT-1754K, MMT-1714K, MMT-1755K - Product Usage: intended for continuous delivery of basal insulin (at user selectable rate
  • Z-0955-2020 · Nov 21, 2019 · Open, Classified
    Medtronic MiniMed 630G System with SmartGuard, Ref/Model # MMT-1515, MMT-1715, MMT-1714, MMT-1754, and MMT-1755 *US and Canada Version Only
  • Z-0683-2019 · Oct 3, 2018 · Open, Classified
    Medtronic MiniMed 630G 6025805-003_C, Rx Only Medtronic MiniMed 670G 6025805-005_B, Rx Only Medtronic MiniMed 640G (International)
  • Z-2602-2017 · May 8, 2017 · Terminated
    MiniMed 620G Insulin Infusion Pump, Catalog No. MMT-1510, MMT-1710, MMT-1550, MMT-1750.
  • Z-2603-2017 · May 8, 2017 · Terminated
    MiniMed 630G Insulin Infusion Pump, Catalog No. MMT-1715, MMT-1755.

Other Artificial pancreas device system, threshold suspend devices

All Artificial pancreas device system, threshold suspend devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page